Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 1 6Phase EARLY_PHASE1 2Phase NA 1Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Prostatic Neoplasms 4Ovarian Neoplasms 4Pancreatic Neoplasms 3Sarcoma 2Hematopoietic and Lymphoid System Neoplasm 2Glioma 2Glioblastoma 2Brain Neoplasms 2Urogenital Neoplasms 1Stomach Neoplasms 1Sarcoma, Synovial 1Rhabdomyosarcoma 1Resectable Pancreatic Carcinoma 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pelvic Neoplasms 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Liposarcoma, Myxoid 1Liposarcoma 1Fallopian Tube Neoplasms 1Endometrial Serous Adenocarcinoma 1Desmoplastic Small Round Cell Tumor 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Adenocarcinoma of Lung 1

Interventions

Magnetic Resonance Spectroscopy 7Temozolomide 6Radiotherapy 6fluciclovine F-18 4Topotecan 4fluorodopa F 18 3Biopsy 3niraparib 2abemaciclib 2Standard of Care 2Specimen Handling 2Pemetrexed 2Ketoconazole 2ulixertinib 1temsirolimus 1ribociclib 1posaconazole 1poly ICLC 1pitavastatin 1pembrolizumab 1orludodstat 1lorlatinib 1larotrectinib 1infigratinib 1fisetin 1fimepinostat 1evolocumab 1clevudine 1X-Rays 1Watchful Waiting 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Glioma × Specimen Handling × Clear all
NCT07025226 2026-01-26

Senolytics

Mayo Clinic

Phase EARLY_PHASE1 Recruiting
10 enrolled
CNS

Glioma

NCT05717153 2025-11-04

Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma

Mayo Clinic

Phase EARLY_PHASE1 Recruiting
18 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡